1000340-35-1 Usage
Description
4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde, with the CAS number 437674-89-6, is a synthetic chemical compound that is predominantly utilized in the field of medicinal chemistry. It is characterized by its solid, off-white crystalline form at room temperature. Due to its reactivity and potential hazardous effects, this compound requires careful handling. The specific properties, such as its melting point or boiling point, may vary depending on the purity and other factors.
Uses
Used in Medicinal Chemistry Research:
4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde is employed as a research compound in medicinal chemistry, serving as a key intermediate in the synthesis of various pharmaceutical agents. Its unique structure and reactivity make it a valuable component in the development of new drugs and therapeutics.
Used in Laboratory Settings:
This chemical is primarily used in laboratory environments, where it is involved in the synthesis and testing of new compounds. Its application is limited to research purposes, and it is not commercially available nor found in any consumer products, ensuring that its potential hazards are contained within controlled settings.
Check Digit Verification of cas no
The CAS Registry Mumber 1000340-35-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,3,4 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1000340-35:
(9*1)+(8*0)+(7*0)+(6*0)+(5*3)+(4*4)+(3*0)+(2*3)+(1*5)=51
51 % 10 = 1
So 1000340-35-1 is a valid CAS Registry Number.
1000340-35-1Relevant articles and documents
PYRROLOPYRIMIDINE ITK INHIBITORS
-
Paragraph 0630; 0631; 0632; 0645; 0646; 0647, (2020/02/27)
Disclosed herein are arylpyridinone compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structures of Formulas (I)-(IV): wherein the R groups, m, n, and X are as defined in the detailed description. Methods of inhibition of ITK activity in a human or animal subject are also provided.
3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
-
Page/Page column 36-37, (2009/12/23)
The invention relates to 3-substituted-1H-pyrrolo[2,3-b]pyridine, and 3-substituted-1H-pyrrolo[3,2-b]pyridine compounds of the Formula 1: or a pharmaceutically acceptable salt thereof, wherein the constituent variables are as defined herein, compositions comprising the compounds, and methods for making and using the compounds.
